|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:IP6K2-CNDP2 (FusionGDB2 ID:40018) |
Fusion Gene Summary for IP6K2-CNDP2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: IP6K2-CNDP2 | Fusion gene ID: 40018 | Hgene | Tgene | Gene symbol | IP6K2 | CNDP2 | Gene ID | 51447 | 55748 |
| Gene name | inositol hexakisphosphate kinase 2 | carnosine dipeptidase 2 | |
| Synonyms | IHPK2|InsP6K2|PIUS | CN2|CPGL|HEL-S-13|HsT2298|PEPA | |
| Cytomap | 3p21.31 | 18q22.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | inositol hexakisphosphate kinase 2ATP:1D-myo-inositol-hexakisphosphate phosphotransferaseinositol hexaphosphate kinase 2insp6 kinase 2pi uptake stimulator | cytosolic non-specific dipeptidaseCNDP dipeptidase 2 (metallopeptidase M20 family)carnosinase-2carnosine dipeptidase IIcytosolic nonspecific dipeptidaseepididymis secretory protein Li 13glutamate carboxypeptidase-like protein 1peptidase A | |
| Modification date | 20200327 | 20200313 | |
| UniProtAcc | Q9UHH9 | Q96KP4 | |
| Ensembl transtripts involved in fusion gene | ENST00000328631, ENST00000340879, ENST00000413298, ENST00000432678, ENST00000450045, ENST00000436134, ENST00000417896, ENST00000431721, ENST00000443964, ENST00000446860, ENST00000449610, ENST00000453202, | ENST00000324301, ENST00000580229, ENST00000324262, ENST00000579847, | |
| Fusion gene scores | * DoF score | 13 X 12 X 7=1092 | 7 X 7 X 4=196 |
| # samples | 20 | 7 | |
| ** MAII score | log2(20/1092*10)=-2.44890095114513 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: IP6K2 [Title/Abstract] AND CNDP2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | IP6K2(48732522)-CNDP2(72186183), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | IP6K2-CNDP2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. IP6K2-CNDP2 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. IP6K2-CNDP2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. IP6K2-CNDP2 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | IP6K2 | GO:0043647 | inositol phosphate metabolic process | 30624931 |
| Hgene | IP6K2 | GO:0046854 | phosphatidylinositol phosphorylation | 10574768 |
| Fusion gene breakpoints across IP6K2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CNDP2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | UCEC | TCGA-AJ-A3OJ | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
Top |
Fusion Gene ORF analysis for IP6K2-CNDP2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000328631 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000328631 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000340879 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000340879 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000413298 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000413298 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000432678 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000432678 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000450045 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5CDS-intron | ENST00000450045 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5UTR-3CDS | ENST00000436134 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5UTR-3CDS | ENST00000436134 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5UTR-intron | ENST00000436134 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| 5UTR-intron | ENST00000436134 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| Frame-shift | ENST00000413298 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| Frame-shift | ENST00000413298 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| Frame-shift | ENST00000432678 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| Frame-shift | ENST00000432678 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| In-frame | ENST00000328631 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| In-frame | ENST00000328631 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| In-frame | ENST00000340879 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| In-frame | ENST00000340879 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| In-frame | ENST00000450045 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| In-frame | ENST00000450045 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000417896 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000417896 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000431721 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000431721 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000443964 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000443964 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000446860 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000446860 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000449610 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000449610 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000453202 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-3CDS | ENST00000453202 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000417896 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000417896 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000431721 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000431721 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000443964 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000443964 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000446860 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000446860 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000449610 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000449610 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000453202 | ENST00000324301 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| intron-intron | ENST00000453202 | ENST00000580229 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000328631 | IP6K2 | chr3 | 48732522 | - | ENST00000324262 | CNDP2 | chr18 | 72186183 | + | 1704 | 426 | 170 | 643 | 157 |
| ENST00000328631 | IP6K2 | chr3 | 48732522 | - | ENST00000579847 | CNDP2 | chr18 | 72186183 | + | 1707 | 426 | 170 | 643 | 157 |
| ENST00000340879 | IP6K2 | chr3 | 48732522 | - | ENST00000324262 | CNDP2 | chr18 | 72186183 | + | 1670 | 392 | 136 | 609 | 157 |
| ENST00000340879 | IP6K2 | chr3 | 48732522 | - | ENST00000579847 | CNDP2 | chr18 | 72186183 | + | 1673 | 392 | 136 | 609 | 157 |
| ENST00000450045 | IP6K2 | chr3 | 48732522 | - | ENST00000324262 | CNDP2 | chr18 | 72186183 | + | 1710 | 432 | 68 | 649 | 193 |
| ENST00000450045 | IP6K2 | chr3 | 48732522 | - | ENST00000579847 | CNDP2 | chr18 | 72186183 | + | 1713 | 432 | 68 | 649 | 193 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000328631 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.009038297 | 0.99096173 |
| ENST00000328631 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.00960282 | 0.9903972 |
| ENST00000340879 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.005849795 | 0.9941502 |
| ENST00000340879 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.006022923 | 0.99397707 |
| ENST00000450045 | ENST00000324262 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.006833162 | 0.99316686 |
| ENST00000450045 | ENST00000579847 | IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.006869227 | 0.99313074 |
Top |
Fusion Genomic Features for IP6K2-CNDP2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.004252967 | 0.995747 |
| IP6K2 | chr3 | 48732522 | - | CNDP2 | chr18 | 72186183 | + | 0.004252967 | 0.995747 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for IP6K2-CNDP2 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:48732522/chr18:72186183) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| IP6K2 | CNDP2 |
| FUNCTION: Converts inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). {ECO:0000269|PubMed:10574768, ECO:0000269|PubMed:30624931}. | FUNCTION: Hydrolyzes a variety of dipeptides including L-carnosine but has a strong preference for Cys-Gly (PubMed:19346245). Acts as a functional tumor suppressor in gastric cancer via activation of the mitogen-activated protein kinase (MAPK) pathway. An elevated level of CNDP2 activates the p38 and JNK MAPK pathways to induce cell apoptosis, and a lower level of CNDP2 activates the ERK MAPK pathway to promote cell proliferation (PubMed:24395568). Isoform 2 may play a role as tumor suppressor in hepatocellular carcinoma (HCC) cells (PubMed:17121880). Catalyzes the production of N-lactoyl-amino acids from lactate and amino acids by reverse proteolysis (PubMed:25964343). {ECO:0000269|PubMed:17121880, ECO:0000269|PubMed:19346245, ECO:0000269|PubMed:24395568, ECO:0000269|PubMed:25964343}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000328631 | - | 2 | 6 | 207_209 | 67 | 427.0 | Nucleotide binding | ATP |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000340879 | - | 2 | 3 | 207_209 | 67 | 98.0 | Nucleotide binding | ATP |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000413298 | - | 3 | 4 | 207_209 | 67 | 98.0 | Nucleotide binding | ATP |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000431721 | - | 1 | 3 | 207_209 | 0 | 186.0 | Nucleotide binding | ATP |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000432678 | - | 2 | 4 | 207_209 | 67 | 221.66666666666666 | Nucleotide binding | ATP |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000446860 | - | 1 | 3 | 207_209 | 0 | 189.0 | Nucleotide binding | ATP |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000328631 | - | 2 | 6 | 236_243 | 67 | 427.0 | Region | Substrate binding |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000340879 | - | 2 | 3 | 236_243 | 67 | 98.0 | Region | Substrate binding |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000413298 | - | 3 | 4 | 236_243 | 67 | 98.0 | Region | Substrate binding |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000431721 | - | 1 | 3 | 236_243 | 0 | 186.0 | Region | Substrate binding |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000432678 | - | 2 | 4 | 236_243 | 67 | 221.66666666666666 | Region | Substrate binding |
| Hgene | IP6K2 | chr3:48732522 | chr18:72186183 | ENST00000446860 | - | 1 | 3 | 236_243 | 0 | 189.0 | Region | Substrate binding |
| Tgene | CNDP2 | chr3:48732522 | chr18:72186183 | ENST00000324262 | 9 | 12 | 166_167 | 403 | 476.0 | Region | Substrate binding | |
| Tgene | CNDP2 | chr3:48732522 | chr18:72186183 | ENST00000324301 | 6 | 9 | 166_167 | 319 | 392.0 | Region | Substrate binding | |
| Tgene | CNDP2 | chr3:48732522 | chr18:72186183 | ENST00000579847 | 9 | 12 | 166_167 | 403 | 476.0 | Region | Substrate binding |
Top |
Fusion Gene Sequence for IP6K2-CNDP2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >40018_40018_1_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000328631_CNDP2_chr18_72186183_ENST00000324262_length(transcript)=1704nt_BP=426nt AGGTGCAGGGGGCGGGGCTCGGCCTGGCCGCAGCCATTTTGGTGCGAGAGAAACAATAGGACGGAAACGCCGAGGAACCCGGCTGAGGCG GCAGCAGAGCATCCTGGCCAGAACAAGCCAAGGAGCCAAGACGAGAGGGACACACGGACAAACAACAGACAGAAGACGTACTGGCCGCTG GACTCCGCTGCCTCCCCCATCTCCCCGCCATCTGCGCCCGGAGGATGAGCCCAGCCTTCAGGGCCATGGATGTGGAGCCCCGCGCCAAAG GCGTCCTTCTGGAGCCCTTTGTCCACCAGGTCGGGGGGCACTCATGCGTGCTCCGCTTCAATGAGACAACCCTGTGCAAGCCCCTGGTCC CAAGGGAACATCAGTTCTACGAGACCCTCCCTGCTGAGATGCGCAAATTCACTCCCCAGTACAAAGTTTTTGGTGTTGAGCCAGACTTGA CCAGGGAAGGCGGCAGTATTCCCGTGACCTTGACCTTTCAGGAGGCCACGGGCAAGAACGTCATGCTGCTGCCTGTGGGGTCAGCGGATG ACGGAGCCCACTCCCAGAATGAAAAGCTCAACAGGTATAACTACATAGAGGGAACCAAGATGCTGGCCGCGTACCTGTATGAGGTCTCCC AGCTGAAGGACTAGGCCAAGCCCTCTGTGTGCCATCTCCAATGAGAAGGAATCCTGCCCTCACCTCACCCTTTTCCAACTTGCCCAGGGA AGTGGAGGTTCCCTCTTTCCTTTCCCTCTTGTCAGGTCATCCATGACTTTAGAGAACAGACACAAGTGTATCCAGCTGTCCACGGGTGGA GCTACCCGTTGGGCTTATGAGTGACCTGGAGTGACAGCTGAGTCACCCTGGGTAAGTTCTCAGAGTGGTCAGGATGGCTTGACCTGCAGA AGATACCCAAGGTCCAAAAGCACAAGGTCTGCGGAAAGTTCTGGTTGTCGGCCGGGCACCACGGCTCACACCTATAATCGAGCACTTTGG GAGGCCAAGACAGGAGGATCACTTGAGGCCAGGAGTCTGAGACAAGCCTAGGCAACAAAACAAGACTCTGTCTCTACAAAAAGTTTAAGA AATGAGCCAGACATGGTGGTGTATGCCTGTAGTCCCAGCCACTCAGAAGGCTGAGGCAGGAGGATCGCTTGAGACCAAGAGTTTGAGCCT GCGGTGAGCTGTGAATGCACCACGGCACTCAAGCCTGGGCAATGTAGCAAGATCCTGTCTCTACAAGAAATTTTTTAAAAATGAGCCAAG TGTGGTGGTGCATGCCTGTAGTTCCAGCTACTCAGGACACTGACGTAGGAGGGTTGCTTGAGACTGAGAGTTGGAGGCTGCGATGAGCCA TGAATGCCCCACTGCACTCCAGCCTGGGCGACAGAACGAGACCCCATCTCAAAAAAAATAAGTTCTGGTTGTCATTGAATTGGGATAAAC AGAGAGCTTGATGCTTTCTGCCTTCTGTCTCAGGTGATGCATTGCACATTTGGGATATTTGGAAAGGAAATGAGGAAAGAAATTAGGGCC TCCTCTGATCTCTCGCTATCTGCGGGTCCTGTCCTTTTCTCAAGACCTTCACCATTACTGGCATTTTCCTGTCTTCTCTTTAGTATGATC >40018_40018_1_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000328631_CNDP2_chr18_72186183_ENST00000324262_length(amino acids)=157AA_BP=85 MAAGLRCLPHLPAICARRMSPAFRAMDVEPRAKGVLLEPFVHQVGGHSCVLRFNETTLCKPLVPREHQFYETLPAEMRKFTPQYKVFGVE -------------------------------------------------------------- >40018_40018_2_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000328631_CNDP2_chr18_72186183_ENST00000579847_length(transcript)=1707nt_BP=426nt AGGTGCAGGGGGCGGGGCTCGGCCTGGCCGCAGCCATTTTGGTGCGAGAGAAACAATAGGACGGAAACGCCGAGGAACCCGGCTGAGGCG GCAGCAGAGCATCCTGGCCAGAACAAGCCAAGGAGCCAAGACGAGAGGGACACACGGACAAACAACAGACAGAAGACGTACTGGCCGCTG GACTCCGCTGCCTCCCCCATCTCCCCGCCATCTGCGCCCGGAGGATGAGCCCAGCCTTCAGGGCCATGGATGTGGAGCCCCGCGCCAAAG GCGTCCTTCTGGAGCCCTTTGTCCACCAGGTCGGGGGGCACTCATGCGTGCTCCGCTTCAATGAGACAACCCTGTGCAAGCCCCTGGTCC CAAGGGAACATCAGTTCTACGAGACCCTCCCTGCTGAGATGCGCAAATTCACTCCCCAGTACAAAGTTTTTGGTGTTGAGCCAGACTTGA CCAGGGAAGGCGGCAGTATTCCCGTGACCTTGACCTTTCAGGAGGCCACGGGCAAGAACGTCATGCTGCTGCCTGTGGGGTCAGCGGATG ACGGAGCCCACTCCCAGAATGAAAAGCTCAACAGGTATAACTACATAGAGGGAACCAAGATGCTGGCCGCGTACCTGTATGAGGTCTCCC AGCTGAAGGACTAGGCCAAGCCCTCTGTGTGCCATCTCCAATGAGAAGGAATCCTGCCCTCACCTCACCCTTTTCCAACTTGCCCAGGGA AGTGGAGGTTCCCTCTTTCCTTTCCCTCTTGTCAGGTCATCCATGACTTTAGAGAACAGACACAAGTGTATCCAGCTGTCCACGGGTGGA GCTACCCGTTGGGCTTATGAGTGACCTGGAGTGACAGCTGAGTCACCCTGGGTAAGTTCTCAGAGTGGTCAGGATGGCTTGACCTGCAGA AGATACCCAAGGTCCAAAAGCACAAGGTCTGCGGAAAGTTCTGGTTGTCGGCCGGGCACCACGGCTCACACCTATAATCGAGCACTTTGG GAGGCCAAGACAGGAGGATCACTTGAGGCCAGGAGTCTGAGACAAGCCTAGGCAACAAAACAAGACTCTGTCTCTACAAAAAGTTTAAGA AATGAGCCAGACATGGTGGTGTATGCCTGTAGTCCCAGCCACTCAGAAGGCTGAGGCAGGAGGATCGCTTGAGACCAAGAGTTTGAGCCT GCGGTGAGCTGTGAATGCACCACGGCACTCAAGCCTGGGCAATGTAGCAAGATCCTGTCTCTACAAGAAATTTTTTAAAAATGAGCCAAG TGTGGTGGTGCATGCCTGTAGTTCCAGCTACTCAGGACACTGACGTAGGAGGGTTGCTTGAGACTGAGAGTTGGAGGCTGCGATGAGCCA TGAATGCCCCACTGCACTCCAGCCTGGGCGACAGAACGAGACCCCATCTCAAAAAAAATAAGTTCTGGTTGTCATTGAATTGGGATAAAC AGAGAGCTTGATGCTTTCTGCCTTCTGTCTCAGGTGATGCATTGCACATTTGGGATATTTGGAAAGGAAATGAGGAAAGAAATTAGGGCC TCCTCTGATCTCTCGCTATCTGCGGGTCCTGTCCTTTTCTCAAGACCTTCACCATTACTGGCATTTTCCTGTCTTCTCTTTAGTATGATC >40018_40018_2_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000328631_CNDP2_chr18_72186183_ENST00000579847_length(amino acids)=157AA_BP=85 MAAGLRCLPHLPAICARRMSPAFRAMDVEPRAKGVLLEPFVHQVGGHSCVLRFNETTLCKPLVPREHQFYETLPAEMRKFTPQYKVFGVE -------------------------------------------------------------- >40018_40018_3_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000340879_CNDP2_chr18_72186183_ENST00000324262_length(transcript)=1670nt_BP=392nt CATTTTGGTGCGAGAGAAACAATAGGACGGAAACGCCGAGGAACCCGGCTGAGGCGGCAGCAGAGCATCCTGGCCAGAACAAGCCAAGGA GCCAAGACGAGAGGGACACACGGACAAACAACAGACAGAAGACGTACTGGCCGCTGGACTCCGCTGCCTCCCCCATCTCCCCGCCATCTG CGCCCGGAGGATGAGCCCAGCCTTCAGGGCCATGGATGTGGAGCCCCGCGCCAAAGGCGTCCTTCTGGAGCCCTTTGTCCACCAGGTCGG GGGGCACTCATGCGTGCTCCGCTTCAATGAGACAACCCTGTGCAAGCCCCTGGTCCCAAGGGAACATCAGTTCTACGAGACCCTCCCTGC TGAGATGCGCAAATTCACTCCCCAGTACAAAGTTTTTGGTGTTGAGCCAGACTTGACCAGGGAAGGCGGCAGTATTCCCGTGACCTTGAC CTTTCAGGAGGCCACGGGCAAGAACGTCATGCTGCTGCCTGTGGGGTCAGCGGATGACGGAGCCCACTCCCAGAATGAAAAGCTCAACAG GTATAACTACATAGAGGGAACCAAGATGCTGGCCGCGTACCTGTATGAGGTCTCCCAGCTGAAGGACTAGGCCAAGCCCTCTGTGTGCCA TCTCCAATGAGAAGGAATCCTGCCCTCACCTCACCCTTTTCCAACTTGCCCAGGGAAGTGGAGGTTCCCTCTTTCCTTTCCCTCTTGTCA GGTCATCCATGACTTTAGAGAACAGACACAAGTGTATCCAGCTGTCCACGGGTGGAGCTACCCGTTGGGCTTATGAGTGACCTGGAGTGA CAGCTGAGTCACCCTGGGTAAGTTCTCAGAGTGGTCAGGATGGCTTGACCTGCAGAAGATACCCAAGGTCCAAAAGCACAAGGTCTGCGG AAAGTTCTGGTTGTCGGCCGGGCACCACGGCTCACACCTATAATCGAGCACTTTGGGAGGCCAAGACAGGAGGATCACTTGAGGCCAGGA GTCTGAGACAAGCCTAGGCAACAAAACAAGACTCTGTCTCTACAAAAAGTTTAAGAAATGAGCCAGACATGGTGGTGTATGCCTGTAGTC CCAGCCACTCAGAAGGCTGAGGCAGGAGGATCGCTTGAGACCAAGAGTTTGAGCCTGCGGTGAGCTGTGAATGCACCACGGCACTCAAGC CTGGGCAATGTAGCAAGATCCTGTCTCTACAAGAAATTTTTTAAAAATGAGCCAAGTGTGGTGGTGCATGCCTGTAGTTCCAGCTACTCA GGACACTGACGTAGGAGGGTTGCTTGAGACTGAGAGTTGGAGGCTGCGATGAGCCATGAATGCCCCACTGCACTCCAGCCTGGGCGACAG AACGAGACCCCATCTCAAAAAAAATAAGTTCTGGTTGTCATTGAATTGGGATAAACAGAGAGCTTGATGCTTTCTGCCTTCTGTCTCAGG TGATGCATTGCACATTTGGGATATTTGGAAAGGAAATGAGGAAAGAAATTAGGGCCTCCTCTGATCTCTCGCTATCTGCGGGTCCTGTCC TTTTCTCAAGACCTTCACCATTACTGGCATTTTCCTGTCTTCTCTTTAGTATGATCCCTCAAAACCTCACTAACTGGAAGGATGATTTTG >40018_40018_3_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000340879_CNDP2_chr18_72186183_ENST00000324262_length(amino acids)=157AA_BP=85 MAAGLRCLPHLPAICARRMSPAFRAMDVEPRAKGVLLEPFVHQVGGHSCVLRFNETTLCKPLVPREHQFYETLPAEMRKFTPQYKVFGVE -------------------------------------------------------------- >40018_40018_4_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000340879_CNDP2_chr18_72186183_ENST00000579847_length(transcript)=1673nt_BP=392nt CATTTTGGTGCGAGAGAAACAATAGGACGGAAACGCCGAGGAACCCGGCTGAGGCGGCAGCAGAGCATCCTGGCCAGAACAAGCCAAGGA GCCAAGACGAGAGGGACACACGGACAAACAACAGACAGAAGACGTACTGGCCGCTGGACTCCGCTGCCTCCCCCATCTCCCCGCCATCTG CGCCCGGAGGATGAGCCCAGCCTTCAGGGCCATGGATGTGGAGCCCCGCGCCAAAGGCGTCCTTCTGGAGCCCTTTGTCCACCAGGTCGG GGGGCACTCATGCGTGCTCCGCTTCAATGAGACAACCCTGTGCAAGCCCCTGGTCCCAAGGGAACATCAGTTCTACGAGACCCTCCCTGC TGAGATGCGCAAATTCACTCCCCAGTACAAAGTTTTTGGTGTTGAGCCAGACTTGACCAGGGAAGGCGGCAGTATTCCCGTGACCTTGAC CTTTCAGGAGGCCACGGGCAAGAACGTCATGCTGCTGCCTGTGGGGTCAGCGGATGACGGAGCCCACTCCCAGAATGAAAAGCTCAACAG GTATAACTACATAGAGGGAACCAAGATGCTGGCCGCGTACCTGTATGAGGTCTCCCAGCTGAAGGACTAGGCCAAGCCCTCTGTGTGCCA TCTCCAATGAGAAGGAATCCTGCCCTCACCTCACCCTTTTCCAACTTGCCCAGGGAAGTGGAGGTTCCCTCTTTCCTTTCCCTCTTGTCA GGTCATCCATGACTTTAGAGAACAGACACAAGTGTATCCAGCTGTCCACGGGTGGAGCTACCCGTTGGGCTTATGAGTGACCTGGAGTGA CAGCTGAGTCACCCTGGGTAAGTTCTCAGAGTGGTCAGGATGGCTTGACCTGCAGAAGATACCCAAGGTCCAAAAGCACAAGGTCTGCGG AAAGTTCTGGTTGTCGGCCGGGCACCACGGCTCACACCTATAATCGAGCACTTTGGGAGGCCAAGACAGGAGGATCACTTGAGGCCAGGA GTCTGAGACAAGCCTAGGCAACAAAACAAGACTCTGTCTCTACAAAAAGTTTAAGAAATGAGCCAGACATGGTGGTGTATGCCTGTAGTC CCAGCCACTCAGAAGGCTGAGGCAGGAGGATCGCTTGAGACCAAGAGTTTGAGCCTGCGGTGAGCTGTGAATGCACCACGGCACTCAAGC CTGGGCAATGTAGCAAGATCCTGTCTCTACAAGAAATTTTTTAAAAATGAGCCAAGTGTGGTGGTGCATGCCTGTAGTTCCAGCTACTCA GGACACTGACGTAGGAGGGTTGCTTGAGACTGAGAGTTGGAGGCTGCGATGAGCCATGAATGCCCCACTGCACTCCAGCCTGGGCGACAG AACGAGACCCCATCTCAAAAAAAATAAGTTCTGGTTGTCATTGAATTGGGATAAACAGAGAGCTTGATGCTTTCTGCCTTCTGTCTCAGG TGATGCATTGCACATTTGGGATATTTGGAAAGGAAATGAGGAAAGAAATTAGGGCCTCCTCTGATCTCTCGCTATCTGCGGGTCCTGTCC TTTTCTCAAGACCTTCACCATTACTGGCATTTTCCTGTCTTCTCTTTAGTATGATCCCTCAAAACCTCACTAACTGGAAGGATGATTTTG >40018_40018_4_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000340879_CNDP2_chr18_72186183_ENST00000579847_length(amino acids)=157AA_BP=85 MAAGLRCLPHLPAICARRMSPAFRAMDVEPRAKGVLLEPFVHQVGGHSCVLRFNETTLCKPLVPREHQFYETLPAEMRKFTPQYKVFGVE -------------------------------------------------------------- >40018_40018_5_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000450045_CNDP2_chr18_72186183_ENST00000324262_length(transcript)=1710nt_BP=432nt CCCTTCCAAGAGGGATGCCAGAGCCTTCTGTAAGCTCCTGAGATGTCACTGGTATCTAGGCAACAGGGATGAGCCTGAACCTCCCTGAGG CCAGCTTACTGAGAGCATCCTGGCCAGAACAAGCCAAGGAGCCAAGACGAGAGGGACACACGGACAAACAACAGACAGAAGACGTACTGG CCGCTGGACTCCGCTGCCTCCCCCATCTCCCCGCCATCTGCGCCCGGAGGATGAGCCCAGCCTTCAGGGCCATGGATGTGGAGCCCCGCG CCAAAGGCGTCCTTCTGGAGCCCTTTGTCCACCAGGTCGGGGGGCACTCATGCGTGCTCCGCTTCAATGAGACAACCCTGTGCAAGCCCC TGGTCCCAAGGGAACATCAGTTCTACGAGACCCTCCCTGCTGAGATGCGCAAATTCACTCCCCAGTACAAAGTTTTTGGTGTTGAGCCAG ACTTGACCAGGGAAGGCGGCAGTATTCCCGTGACCTTGACCTTTCAGGAGGCCACGGGCAAGAACGTCATGCTGCTGCCTGTGGGGTCAG CGGATGACGGAGCCCACTCCCAGAATGAAAAGCTCAACAGGTATAACTACATAGAGGGAACCAAGATGCTGGCCGCGTACCTGTATGAGG TCTCCCAGCTGAAGGACTAGGCCAAGCCCTCTGTGTGCCATCTCCAATGAGAAGGAATCCTGCCCTCACCTCACCCTTTTCCAACTTGCC CAGGGAAGTGGAGGTTCCCTCTTTCCTTTCCCTCTTGTCAGGTCATCCATGACTTTAGAGAACAGACACAAGTGTATCCAGCTGTCCACG GGTGGAGCTACCCGTTGGGCTTATGAGTGACCTGGAGTGACAGCTGAGTCACCCTGGGTAAGTTCTCAGAGTGGTCAGGATGGCTTGACC TGCAGAAGATACCCAAGGTCCAAAAGCACAAGGTCTGCGGAAAGTTCTGGTTGTCGGCCGGGCACCACGGCTCACACCTATAATCGAGCA CTTTGGGAGGCCAAGACAGGAGGATCACTTGAGGCCAGGAGTCTGAGACAAGCCTAGGCAACAAAACAAGACTCTGTCTCTACAAAAAGT TTAAGAAATGAGCCAGACATGGTGGTGTATGCCTGTAGTCCCAGCCACTCAGAAGGCTGAGGCAGGAGGATCGCTTGAGACCAAGAGTTT GAGCCTGCGGTGAGCTGTGAATGCACCACGGCACTCAAGCCTGGGCAATGTAGCAAGATCCTGTCTCTACAAGAAATTTTTTAAAAATGA GCCAAGTGTGGTGGTGCATGCCTGTAGTTCCAGCTACTCAGGACACTGACGTAGGAGGGTTGCTTGAGACTGAGAGTTGGAGGCTGCGAT GAGCCATGAATGCCCCACTGCACTCCAGCCTGGGCGACAGAACGAGACCCCATCTCAAAAAAAATAAGTTCTGGTTGTCATTGAATTGGG ATAAACAGAGAGCTTGATGCTTTCTGCCTTCTGTCTCAGGTGATGCATTGCACATTTGGGATATTTGGAAAGGAAATGAGGAAAGAAATT AGGGCCTCCTCTGATCTCTCGCTATCTGCGGGTCCTGTCCTTTTCTCAAGACCTTCACCATTACTGGCATTTTCCTGTCTTCTCTTTAGT ATGATCCCTCAAAACCTCACTAACTGGAAGGATGATTTTGTCTCAGTTTGTACTCCTAAATAAAAAGTAAACATGACACCTCTAAAAGAA >40018_40018_5_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000450045_CNDP2_chr18_72186183_ENST00000324262_length(amino acids)=193AA_BP=121 MSLNLPEASLLRASWPEQAKEPRREGHTDKQQTEDVLAAGLRCLPHLPAICARRMSPAFRAMDVEPRAKGVLLEPFVHQVGGHSCVLRFN ETTLCKPLVPREHQFYETLPAEMRKFTPQYKVFGVEPDLTREGGSIPVTLTFQEATGKNVMLLPVGSADDGAHSQNEKLNRYNYIEGTKM -------------------------------------------------------------- >40018_40018_6_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000450045_CNDP2_chr18_72186183_ENST00000579847_length(transcript)=1713nt_BP=432nt CCCTTCCAAGAGGGATGCCAGAGCCTTCTGTAAGCTCCTGAGATGTCACTGGTATCTAGGCAACAGGGATGAGCCTGAACCTCCCTGAGG CCAGCTTACTGAGAGCATCCTGGCCAGAACAAGCCAAGGAGCCAAGACGAGAGGGACACACGGACAAACAACAGACAGAAGACGTACTGG CCGCTGGACTCCGCTGCCTCCCCCATCTCCCCGCCATCTGCGCCCGGAGGATGAGCCCAGCCTTCAGGGCCATGGATGTGGAGCCCCGCG CCAAAGGCGTCCTTCTGGAGCCCTTTGTCCACCAGGTCGGGGGGCACTCATGCGTGCTCCGCTTCAATGAGACAACCCTGTGCAAGCCCC TGGTCCCAAGGGAACATCAGTTCTACGAGACCCTCCCTGCTGAGATGCGCAAATTCACTCCCCAGTACAAAGTTTTTGGTGTTGAGCCAG ACTTGACCAGGGAAGGCGGCAGTATTCCCGTGACCTTGACCTTTCAGGAGGCCACGGGCAAGAACGTCATGCTGCTGCCTGTGGGGTCAG CGGATGACGGAGCCCACTCCCAGAATGAAAAGCTCAACAGGTATAACTACATAGAGGGAACCAAGATGCTGGCCGCGTACCTGTATGAGG TCTCCCAGCTGAAGGACTAGGCCAAGCCCTCTGTGTGCCATCTCCAATGAGAAGGAATCCTGCCCTCACCTCACCCTTTTCCAACTTGCC CAGGGAAGTGGAGGTTCCCTCTTTCCTTTCCCTCTTGTCAGGTCATCCATGACTTTAGAGAACAGACACAAGTGTATCCAGCTGTCCACG GGTGGAGCTACCCGTTGGGCTTATGAGTGACCTGGAGTGACAGCTGAGTCACCCTGGGTAAGTTCTCAGAGTGGTCAGGATGGCTTGACC TGCAGAAGATACCCAAGGTCCAAAAGCACAAGGTCTGCGGAAAGTTCTGGTTGTCGGCCGGGCACCACGGCTCACACCTATAATCGAGCA CTTTGGGAGGCCAAGACAGGAGGATCACTTGAGGCCAGGAGTCTGAGACAAGCCTAGGCAACAAAACAAGACTCTGTCTCTACAAAAAGT TTAAGAAATGAGCCAGACATGGTGGTGTATGCCTGTAGTCCCAGCCACTCAGAAGGCTGAGGCAGGAGGATCGCTTGAGACCAAGAGTTT GAGCCTGCGGTGAGCTGTGAATGCACCACGGCACTCAAGCCTGGGCAATGTAGCAAGATCCTGTCTCTACAAGAAATTTTTTAAAAATGA GCCAAGTGTGGTGGTGCATGCCTGTAGTTCCAGCTACTCAGGACACTGACGTAGGAGGGTTGCTTGAGACTGAGAGTTGGAGGCTGCGAT GAGCCATGAATGCCCCACTGCACTCCAGCCTGGGCGACAGAACGAGACCCCATCTCAAAAAAAATAAGTTCTGGTTGTCATTGAATTGGG ATAAACAGAGAGCTTGATGCTTTCTGCCTTCTGTCTCAGGTGATGCATTGCACATTTGGGATATTTGGAAAGGAAATGAGGAAAGAAATT AGGGCCTCCTCTGATCTCTCGCTATCTGCGGGTCCTGTCCTTTTCTCAAGACCTTCACCATTACTGGCATTTTCCTGTCTTCTCTTTAGT ATGATCCCTCAAAACCTCACTAACTGGAAGGATGATTTTGTCTCAGTTTGTACTCCTAAATAAAAAGTAAACATGACACCTCTAAAAGAA >40018_40018_6_IP6K2-CNDP2_IP6K2_chr3_48732522_ENST00000450045_CNDP2_chr18_72186183_ENST00000579847_length(amino acids)=193AA_BP=121 MSLNLPEASLLRASWPEQAKEPRREGHTDKQQTEDVLAAGLRCLPHLPAICARRMSPAFRAMDVEPRAKGVLLEPFVHQVGGHSCVLRFN ETTLCKPLVPREHQFYETLPAEMRKFTPQYKVFGVEPDLTREGGSIPVTLTFQEATGKNVMLLPVGSADDGAHSQNEKLNRYNYIEGTKM -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for IP6K2-CNDP2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for IP6K2-CNDP2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for IP6K2-CNDP2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies